tiprankstipranks
Is ADVM a Buy, Before Earnings?
PremiumPre-EarningsIs ADVM a Buy, Before Earnings?
1M ago
Adverum Biotechnologies Advances in Gene Therapy Development
Premium
Company Announcements
Adverum Biotechnologies Advances in Gene Therapy Development
1M ago
Adverum Biotechnologies reports Q3 EPS ($1.30), consensus ($1.31)
Premium
The Fly
Adverum Biotechnologies reports Q3 EPS ($1.30), consensus ($1.31)
1M ago
Adverum Biotechnologies reports inducement grants under Nasdaq listing rule
PremiumThe FlyAdverum Biotechnologies reports inducement grants under Nasdaq listing rule
3M ago
Adverum Biotechnologies price target lowered to $40 from $60 at Truist
Premium
The Fly
Adverum Biotechnologies price target lowered to $40 from $60 at Truist
4M ago
Adverum Biotechnologies price target lowered to $12 from $15 at RBC Capital
Premium
The Fly
Adverum Biotechnologies price target lowered to $12 from $15 at RBC Capital
4M ago
Adverum Biotechnologies’ Promising AMD Treatment Advances
PremiumCompany AnnouncementsAdverum Biotechnologies’ Promising AMD Treatment Advances
5M ago
4D Molecular price target lowered to $40 from $63 at BMO Capital
Premium
The Fly
4D Molecular price target lowered to $40 from $63 at BMO Capital
5M ago
Adverum Biotechnologies to host conference call
Premium
The Fly
Adverum Biotechnologies to host conference call
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100